Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Change in Taxes (2023 - 2025)

Mangoceuticals' Change in Taxes history spans 3 years, with the latest figure at $4961.0 for Q4 2025.

  • On a quarterly basis, Change in Taxes rose 188.91% to $4961.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1761.0, a 126.7% increase, with the full-year FY2025 number at $9421.0, up 242.85% from a year prior.
  • Change in Taxes hit $4961.0 in Q4 2025 for Mangoceuticals, up from $1487.0 in the prior quarter.
  • Over the last five years, Change in Taxes for MGRX hit a ceiling of $4961.0 in Q4 2025 and a floor of -$5580.0 in Q4 2024.
  • Historically, Change in Taxes has averaged $40.38 across 3 years, with a median of $1190.0 in 2024.
  • Biggest five-year swings in Change in Taxes: crashed 247.66% in 2024 and later surged 188.91% in 2025.
  • Tracing MGRX's Change in Taxes over 3 years: stood at -$1605.0 in 2023, then crashed by 247.66% to -$5580.0 in 2024, then surged by 188.91% to $4961.0 in 2025.
  • Business Quant data shows Change in Taxes for MGRX at $4961.0 in Q4 2025, $1487.0 in Q3 2025, and -$5580.0 in Q4 2024.